期刊文献+

艾滋病预防控制与循证医学 被引量:2

下载PDF
导出
摘要 为了控制艾滋病的蔓延和传播,人类社会每年都要投入巨额资源,但资源的相对有限性和健康需求的多样性,使得艾滋病防制工作的效率和效果成为决策者普遍关注的问题。而随着循证医学的发展和循证决策的思想日渐深入人心,循证医学也为艾滋病防制的科学决策提供了新的思路。但是,尽管循证医学的理论和方法已经较为成熟,如何把这种源于临床实践的决策思想运用到需要大量行为学、社会学工作的艾滋病防制领域,却需要从方法学上做更深入的研究和探讨。该文选择艾滋病防制决策中证据的判定标准、防制效果及效率的区分两个比较重要的问题进行了初步讨论,并对艾滋病防制工作中的循证实践提出建议。
出处 《中国艾滋病性病》 CAS 2008年第1期90-92,共3页 Chinese Journal of Aids & STD
  • 相关文献

参考文献12

  • 1Guyattm, G. Drummond, et al. User's Guides to the Medical Literature: A Manual for Evidence-Based Practice. Chicago[M]. American Medical Association. 2002.
  • 2Cabinet Office. Modernising government Stationery Office: London [R]. 1999.
  • 3唐金陵,Muir Gray.循证医学:循证医疗卫生决策[M].北京:北京大学医学出版社,2004.
  • 4UNAIDS. Report on the Global AIDS Pandemic: A UNAIDS 10th Anniversary Special Edition [ R ]. Geneva: UNAIDS. 2006.
  • 5National Intelligence Council, “The Next Wave of AIDS: Nigeria, Ethiopia, India, Russia and China” prepared under the auspices of David F. Gordon [ R ]. Washington, D. C., Sept. 2002.
  • 6J. Stover, N. Walker, et al. Can we reverse the HIV/AIDS pandemic with an expanded response[J]? Lancet,2002,360(9,326) :73-78.
  • 7Davies P,Boruch R,The Campbell Collaboration. Does for public policy what Cochrane does for health[J]. BMJ,2001, (2) :294-5.
  • 8Richard Cookson. Evidence-based policy making in health care: what it is and what it isn't[J] .J Health Serv Res Policy,2005,10(2).
  • 9Pawson, R. Evidence-based policy: The promise of' Realist Synthesis' [J]. Evaluation, 2002,8 (3) :340-358.
  • 10UNITED NATIONS. Policy Updates:At the United Nations, the U. S. Once Again Opposes the Role of Evidence in HIV Prevention[R]. 2006.

同被引文献33

  • 1吴慧.医学图书馆员和循证医学[J].中国实用医药,2007,2(6):18-19. 被引量:3
  • 2王秉康,刘红鹰.循证医学实践和医院图书馆的信息服务[J].中华医学图书情报杂志,2005,14(1):21-22. 被引量:18
  • 3Gianvecchio RP, Goldberg TB Protective and risk factors related to vertical transmission of the HIV-1 [J].Cad Saude Publica, 2005, 21(2) : 581-588.
  • 4Liu M, Liang WN, Chen Q, etal. Risk factors for the death of SARS in Beijing, 2003[J]. Biomed Environ Sci, 2006, 19(5): 336-339.
  • 5Mo H, Zeng G, Ren X, et al. Longitudinal profile of antibodies against SARS-coronavirus in SARs patients and their clinical significance[J]. Respirology, 2006, 11(1): 49-53.
  • 6Cao WC, Liu W, Zhang PH, et al. Disappearance of antibodies to SARS-associated coronavlrus after recovery[J]. N Engl J Med, 2007, 357(11): 1162-1163.
  • 7The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans[J]. N Engl J Med, 2005, 353(13): 1374-1385.
  • 8Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1)[J]. N Engl J Med, 2005, 352 (4) : 333-340.
  • 9Fang LQ, de Vlas SJ, Liang S, et al. Environmental factors contributing to the spread of HSN1 avian influenza in China's Mainland[J]. PLoS One, 2008, 3(5) : e2268.
  • 10Myers KP, Olsen CW, Setterquist SF, etal. Are swine workers in the United States at increased risk of infection with zoonotic influenza virus[J].? Clin Infect Dis, 2006, 42 (1): 14-20.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部